These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38408)

  • 1. Selective stimulation of central alpha-autoreceptors following treatment with alpha-methyldopa and FLA 136.
    Andén NE
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):263-6. PubMed ID: 38408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenaline synthesis and utilization: control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoreceptor blocking agents.
    Grabowska M; Andén NE
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):53-8. PubMed ID: 6919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLA 136: selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline.
    Andén NE; Grabowska M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jul; 298(3):239-43. PubMed ID: 19710
    [No Abstract]   [Full Text] [Related]  

  • 4. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.
    Andén NE; Grabowska M; Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):43-52. PubMed ID: 6918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the cardiovascular and sedative actions of the alpha-adrenoceptor agonists, FLA-136 and clonidine, in the rat.
    Hamilton TC; Longman SD
    Br J Pharmacol; 1982 Jan; 75(1):13-21. PubMed ID: 6122478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.
    Finch L; Haeusler G
    Br J Pharmacol; 1973 Feb; 47(2):217-28. PubMed ID: 4722038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-methyldopa reduces locomotor activity in rats via its metabolite, alpha-methylnorepinephrine, acting on alpha 2-adrenoceptors.
    Clineschmidt BV; Flataker LM; Faison EP; Haubrich DR
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):231-43. PubMed ID: 6250499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the pharmacology of alpha-methyl-3,4-dihydroxyphenylalanine (alpha-methyl-dopa) and alpha-methylnorepinephrine. II.
    Kadzielawa K
    Int J Neuropharmacol; 1967 Nov; 6(6):453-62. PubMed ID: 5300898
    [No Abstract]   [Full Text] [Related]  

  • 9. -Sympathetic receptor stimulation in the brain and hypotensive activity of -methyldopa.
    Heise A; Kroneberg G
    Eur J Pharmacol; 1972 Feb; 17(2):315-7. PubMed ID: 4402101
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective blockade of brain alpha 2-autoreceptors by yohimbine: effects on motor activity and on turnover of noradrenaline and dopamine.
    Andén NE; Pauksens K; Svensson K
    J Neural Transm; 1982; 55(2):111-20. PubMed ID: 6294237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain.
    Andén N; Grabowska M
    Eur J Pharmacol; 1976 Oct; 39(2):275-82. PubMed ID: 185062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.
    Andén NE; Fuxe K
    Br J Pharmacol; 1971 Dec; 43(4):747-56. PubMed ID: 4339882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action of alpha-methyldopa and its metabolites on the preferential liberation of newly synthesized 3H noradrenaline].
    Cohen Y; Rapin J; Jacquot C; Hamar C
    C R Acad Hebd Seances Acad Sci D; 1973 Oct; 277(15):1581-3. PubMed ID: 4204872
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of bretylium on the interactions of infused sympathomi- metic amines and tyramine in the reserpine-treated pithed rat.
    Clarke DE; Leach GD
    Br J Pharmacol Chemother; 1968 Feb; 32(2):392-401. PubMed ID: 4384657
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic effects of mianserin on noradrenaline metabolism in the rat brain: evidence for a pre-synaptic alpha-adrenolytic action in vivo.
    Fludder JM; Leonard BE
    Psychopharmacology (Berl); 1979 Sep; 64(3):329-32. PubMed ID: 41280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alpha-methyldopa and alpha-methyl-m-tyrosine on the amount of noradrenaline in the heart and brain of irradiated rats.
    Stepanović SR; Nikolić JV; Varagić VM
    Strahlentherapie; 1977 Jun; 153(6):426-30. PubMed ID: 877979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE; Engel J
    Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
    [No Abstract]   [Full Text] [Related]  

  • 19. Methyldopa produces central inhibition of parasympathetic activity in the cat.
    Koss MC
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov; 314(2):135-9. PubMed ID: 6256665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic actions of alpha-methylnoradrenaline derived from alpha-methyldopa.
    Boakes RJ; Candy JM; Wolstencroft JH
    J Pharm Pharmacol; 1973 Jun; 25(6):491-2. PubMed ID: 4146591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.